跳至主要内容
临床试验/IRCT20240629062278N1
IRCT20240629062278N1招募中3 期

The Effects of probiotic supplementation on related side effects after chemotherapy and laboratory symptoms in metastatic gastrointestinal cancer patients:A randomized control trial

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 160 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • 65-18 years old with metastatic GI cancer undergoing chemotherapy
  • No lactose intolerance
  • Did not have any symptoms of diarrhea, constipation, nausea, vomiting, or mucositis before receiving chemotherapy,
  • Functional status 0 or 1 according to ECOG (Eastern Cooperative Oncology Group)

排除标准

  • Reluctance of the patient to participate in the study
  • Description of underlying diseases including IBD
  • \History of Colectomy
  • Taking any antibiotic or other drugs

研究者

相似试验